Recruiting

Parasitic Infection Evaluation and Treatment

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe and evaluate the diagnosis, treatment, and progression of various parasitic infections in individuals.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Vector Borne Diseases+5

+ Mosquito-Borne Diseases

+ Helminthiasis

Over 3 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: October 1998
See protocol details

Summary

Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Study ContactThomas B Nutman, M.D.More contacts
Last updated: July 23, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 10, 1998

Actual date on which the first participant was enrolled.

This study is designed as a prospective study to evaluate and treat patients with parasitic infection. Patients with known or suspected parasitic infection will be enrolled and will be evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit will include a medical history, physical examination, routine laboratory tests, and specialized diagnostic procedures for possible parasitic infections. Treatment plans will be individualized for each patient's particular condition, and the number and length of additional visits and diagnostic evaluations will vary accordingly. Specific treatment regimens will be in accordance with standard medical practice.

NCT00001645
Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Study ContactThomas B Nutman, M.D.More contacts
Last updated: July 23, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

800 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 3 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Vector Borne DiseasesMosquito-Borne DiseasesHelminthiasisInfectionsParasitic DiseasesProtozoan InfectionsMalariaTrematode Infections

Criteria

3 inclusion criteria required to participate
Access to a primary medical care provider outside of the NIH
Age 3 or over
Clinical evidence suggestive of a parasitic infection
2 exclusion criteria prevent from participating
Less than 3 years of age
No evidence suggestive of a parasitic infection

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

5 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

National Institutes of Health Clinical Center

Bethesda, United StatesOpen National Institutes of Health Clinical Center in Google Maps
Recruiting
One Study Center